NIR collecting 11 year Tdap information

Monday, 24 June 2013

The Ministry of Health is enabling the National Immunisation Register (NIR) to collect information on the 11 year old Tdap immunisation event.

Manual entry of the dTap-11Y vaccination event

The Ministry of Health is enabling capability for manual entry only of the dTap-11Y vaccination event, allowing for the event to be recorded on the NIR.

The child's nominated provider will receive notification of the vaccination event being loading onto the NIR in their PMS provider in-box for acceptance. The dTap-11Y event needs to be the event scheduled in the PMS, and not the historic AG-dTap-IPV-11Y to ensure the vaccination update is successful.

For electronic loading of the dTap-11Y vaccination event via SBVS or PMS systems

The birth cohort rule currently prohibits the electronic loading of dTap-11Y vaccination events onto the NIR for children born before 2005.

This issue is continuing to be worked on by the software vendor Orion to enable all dTap-11Y vaccination events to be electronically captured.

Show in archive
Archive Date: 



Boostrix® is used for booster vaccination of adolescents aged 11 years and pregnant women between 28-38 weeks gestation* to protect against diphtheria, tetanus and pertussis (whooping cough). Boostrix® can also be used for catch-up immunisation for children aged 7 years# to under 18 years.

*After immunisation protection against pertussis takes up to two weeks to develop. Whilst immunisation between 38-40 weeks gestation is still safe for mother and baby later immunisation means the newborn may still be exposed to the disease by their mother on delivery and/or during the first two weeks of life. The PHARMAC decision to limit funded Boostrix® to 28-38 weeks gestation maximises the benefit of immunisation against pertussis whilst being accountable for the use of public funds. Pregnant women can choose to purchase Boostrix® privately after 38 weeks gestation or at any time after delivery.

#Although Boostrix® is not licensed for use in children aged 7 years to under 10 years it has been used in New Zealand and overseas in this age group and there are no safety concerns with off-label use.

Subscribe to RSS - Tdap